Edwards Lifesciences (EW) Finished Goods (2010 - 2026)

Edwards Lifesciences' Finished Goods history runs 13 years deep, the most recent figure standing at $674.4 million for Q1 2026.

• In Q1 2026, Finished Goods rose 13.44% year-over-year to $674.4 million; the TTM figure through Mar 2026 stood at $674.4 million (up 13.44% YoY), while the FY2025 annual figure was $676.7 million, up 11.04% from the prior year.
• Finished Goods was $674.4 million for Q1 2026 at Edwards Lifesciences, roughly flat from $676.7 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $676.7 million in Q4 2025 to a low of $511.4 million in Q4 2023.
• Historically, Finished Goods has averaged $617.2 million across 4 years, with a median of $620.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Finished Goods rose 19.16% in 2024, then fell 11.1% in 2025.
• A 4-year view of Finished Goods shows it stood at $511.4 million in 2023, then grew by 19.16% to $609.4 million in 2024, then gained by 11.04% to $676.7 million in 2025, then dropped by 0.34% to $674.4 million in 2026.
• The last three Finished Goods figures came in at $674.4 million (Q1 2026), $676.7 million (Q4 2025), and $642.2 million (Q3 2025), per Business Quant data.